Loading...
•
Dec 31, 2021
Health Catalyst Q4 2021 Earnings Report
Achieved strong performance with revenue and Adjusted EBITDA exceeding guidance midpoint, and team member engagement in the 96th percentile.
Key Takeaways
Health Catalyst reported strong Q4 2021 performance, exceeding revenue and Adjusted EBITDA guidance. They also reported team member engagement scores in the 96th percentile. For the full year 2021, the company is proud of its financial performance.
Exceeded the mid-point of quarterly guidance for both revenue and Adjusted EBITDA.
Team member engagement scores measured in the 96th percentile.
Welcomed greater than 150 new teammates, including those from the Twistle acquisition.
Demonstrated a consistent track record related to actual quarterly revenue and Adjusted EBITDA performance relative to guidance.
Forward Guidance
Health Catalyst provides forward-looking guidance on total revenue, a GAAP measure, and Adjusted EBITDA, a non-GAAP measure.
Positive Outlook
- Total revenue between $64.0 million and $67.0 million for Q1 2022
- Adjusted EBITDA between $(2.5) million and $(0.5) million for Q1 2022
- Total revenue between $287.8 million and $292.8 million for the full year of 2022
- Adjusted EBITDA between $(4.0) million and $(2.0) million for the full year of 2022
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...